phentolamine has been researched along with Active Hyperemia in 26 studies
Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Second, either saline or the NO synthase inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME, 4 mg/kg) was infused, and perfusion during adenosine-induced hyperemia was determined." | 9.09 | Influence of nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia. ( Buus, NH; Bøttcher, M; Hermansen, F; Mulvany, MJ; Nielsen, TT; Sander, M, 2001) |
| " Second, either saline or the NO synthase inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME, 4 mg/kg) was infused, and perfusion during adenosine-induced hyperemia was determined." | 5.09 | Influence of nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia. ( Buus, NH; Bøttcher, M; Hermansen, F; Mulvany, MJ; Nielsen, TT; Sander, M, 2001) |
| " This selective localization of Annexin A5 was reduced by ischemic preconditioning (10 minutes of ischemia plus reperfusion before ischemic exercise) or by infusion of adenosine into the brachial artery to 6+/-1% and 10+/-3%, respectively (P<0." | 3.73 | Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. ( Boerman, OC; Oyen, WJ; Ramakers, BP; Riksen, NP; Rongen, GA; Smits, P; Steinmetz, N, 2005) |
| "Fractional flow reserve (FFR, calculated by coronary pressure measurements during adenosine-induced hyperaemia) was assessed in 85 patients with an intermediate coronary stenosis (mean diameter stenosis of 50+/-1%) and normal left ventricular function which were divided into the following three groups: (a) 33 patients before and after IC bolus of phentolamine, an alpha1-, alpha2-adrenergic blocker; (b) 32 patients before and after IC bolus of urapidil, a selective alpha1-adrenergic blocker; (c) 20 patients before and after IC bolus of saline." | 3.72 | Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses. ( Aarnoudse, W; Barbato, E; Bartunek, J; De Bruyne, B; Heyndrickx, GR; Pijls, NH; Staelens, F; Vanderheyden, M; Wijns, W, 2004) |
| " The response of the resistance bed in the forearm after release of inflow occlusion (reactive hyperemia), to hand exercise, and to local heating and the response of the calf resistance vessels to arterial occlusion and intra-arterial sodium nitrite and phentolamine were studied in 23 patients with congestive heart failure and 21 normal subjects." | 3.64 | A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. ( Braunwald, E; Mason, DT; Zelis, R, 1968) |
| "Finally, there was a decrease in reactive hyperemia to 15 min of forearm ischemia after the hypoxic exposure." | 1.35 | Ventilatory, hemodynamic, sympathetic nervous system, and vascular reactivity changes after recurrent nocturnal sustained hypoxia in humans. ( Curley, M; Gilmartin, GS; Tamisier, R; Weiss, JW, 2008) |
| "NO inhibition and type 2 diabetes abolished this correlation." | 1.34 | Impact of type 2 diabetes on nitric oxide and adrenergic modulation of myocardial perfusion. ( Buus, NH; Bøtker, HE; Bøttcher, M; Madsen, MM; Nielsen, TT; Schmitz, O; Søndergaard, HM, 2007) |
| " A decline in mean arterial pressure was observed in both groups with increasing dosage of phentolamine." | 1.32 | Preserved alpha-adrenergic tone in the leg vascular bed of spinal cord-injured individuals. ( Hopman, MT; Kooijman, M; Rongen, GA; Smits, P, 2003) |
| "During reactive hyperemia, capillary flow increased more than 100% (p less than 0." | 1.26 | Direct measurement of arteriovenous anastomotic blood flow after lumbar sympathectomy. ( Cronenwett, JL; Lindenauer, SM, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (46.15) | 18.7374 |
| 1990's | 1 (3.85) | 18.2507 |
| 2000's | 9 (34.62) | 29.6817 |
| 2010's | 3 (11.54) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Pepose, J | 1 |
| Brigell, M | 1 |
| Lazar, E | 1 |
| Heisel, C | 1 |
| Yousif, J | 1 |
| Rahmani, K | 1 |
| Kolli, A | 1 |
| Hwang, M | 1 |
| Mitrano, C | 1 |
| Lazar, A | 1 |
| Charizanis, K | 1 |
| Sooch, M | 1 |
| McDonald, M | 1 |
| Gilmartin, GS | 1 |
| Tamisier, R | 1 |
| Curley, M | 1 |
| Weiss, JW | 1 |
| Casey, DP | 1 |
| Madery, BD | 1 |
| Pike, TL | 1 |
| Eisenach, JH | 1 |
| Dietz, NM | 2 |
| Joyner, MJ | 2 |
| Wilkins, BW | 1 |
| Green, DJ | 1 |
| Thijssen, DH | 1 |
| Jiang, B | 1 |
| Seddon, M | 1 |
| Fok, H | 1 |
| Donald, A | 1 |
| Chowienczyk, P | 1 |
| Crecelius, AR | 1 |
| Kirby, BS | 1 |
| Voyles, WF | 1 |
| Dinenno, FA | 1 |
| Kooijman, M | 1 |
| Rongen, GA | 2 |
| Smits, P | 2 |
| Hopman, MT | 1 |
| Barbato, E | 2 |
| Bartunek, J | 1 |
| Aarnoudse, W | 2 |
| Vanderheyden, M | 1 |
| Staelens, F | 1 |
| Wijns, W | 1 |
| Heyndrickx, GR | 1 |
| Pijls, NH | 2 |
| De Bruyne, B | 2 |
| Oyen, WJ | 1 |
| Ramakers, BP | 1 |
| Riksen, NP | 1 |
| Boerman, OC | 1 |
| Steinmetz, N | 1 |
| Geven, M | 1 |
| Botman, KJ | 1 |
| Madsen, MM | 1 |
| Søndergaard, HM | 1 |
| Bøttcher, M | 2 |
| Buus, NH | 2 |
| Schmitz, O | 1 |
| Bøtker, HE | 1 |
| Nielsen, TT | 2 |
| Moradkhan, R | 1 |
| McQuillan, P | 1 |
| Hogeman, C | 1 |
| Leuenberger, A | 1 |
| Linton-Frazier, L | 1 |
| Leuenberger, UA | 1 |
| Uusitalo, H | 1 |
| Engelke, KA | 1 |
| Williams, MM | 1 |
| Hermansen, F | 1 |
| Sander, M | 1 |
| Mulvany, MJ | 1 |
| Schwartz, PJ | 1 |
| Stone, HL | 1 |
| Cronenwett, JL | 1 |
| Lindenauer, SM | 1 |
| Juhász-Nagy, A | 1 |
| Urbanics, R | 1 |
| Bache, RJ | 1 |
| Cobb, FR | 1 |
| Ebert, PA | 1 |
| Greenfield, JC | 1 |
| Hinshaw, LB | 1 |
| Page, BB | 1 |
| Brake, CM | 1 |
| Emerson, TE | 1 |
| Honda, N | 1 |
| Morikawa, A | 1 |
| Nihei, H | 1 |
| Aizawa, C | 1 |
| Yoshitoshi, Y | 1 |
| Zelis, R | 2 |
| Longhurst, J | 1 |
| Capone, RJ | 1 |
| Mason, DT | 2 |
| Brown, JH | 1 |
| Garrett, RL | 1 |
| Hopkins, RW | 1 |
| Adamson, AR | 1 |
| Grahame-Smith, DG | 1 |
| Peart, WS | 1 |
| Braunwald, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Single Dose Study of Phentolamine Mesylate Eye Drops in Patients With Severe Night Vision Disturbances[NCT04004507] | Phase 2 | 24 participants (Actual) | Interventional | 2007-08-31 | Completed | ||
| Cardiovascular and Metabolic Physiological Adaptations to Intermittent Hypoxia. Physiological Aspects and Expression of Receptors and Cellular Mediators[NCT02058823] | Phase 4 | 12 participants (Actual) | Interventional | 2013-08-07 | Terminated (stopped due to budget constraints) | ||
| The Association of CPAP Compliance and Nocturnal Hypoxemia in the Perioperative Period[NCT02796846] | 158 participants (Actual) | Observational | 2015-06-30 | Completed | |||
| The Endothelium Dysfunction in Patients of Obstructive Sleep Apnea Syndrome[NCT01699126] | Phase 4 | 46 participants (Actual) | Interventional | 2010-05-31 | Completed | ||
| Caffeine Reduces Acute Ischemic Preconditioning[NCT00184912] | 24 participants | Interventional | 2003-09-30 | Completed | |||
| The Effect of Rosiglitazone on Ischemia-reperfusion-injury Using Annexin A5 Scintigraphy. A Double Blind Placebo- Controlled Cross-over Study in Subjects With the Metabolic Syndrome[NCT00405015] | Phase 2 | 13 participants (Actual) | Interventional | 2007-04-30 | Completed | ||
| Opioid Induced Acute Preconditioning[NCT00184938] | 40 participants (Anticipated) | Interventional | 2005-01-31 | Suspended | |||
| Does Rosuvastatin Reduce Ischemia/Reperfusion Injury in Humans In-Vivo? A Randomized Double Blind Placebo Controlled Trial[NCT00315510] | Phase 2 | 20 participants | Interventional | 2006-04-30 | Completed | ||
| Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?[NCT00430170] | Phase 4 | 20 participants (Actual) | Interventional | 2007-01-31 | Completed | ||
| Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?[NCT00441597] | Phase 4 | 30 participants (Anticipated) | Interventional | 2007-02-28 | Completed | ||
| Effect of Ischemic Postconditioning on Targeting of Annexin A5 After Forearm Exercise[NCT00441714] | 0 participants (Actual) | Interventional | 2007-10-31 | Withdrawn (stopped due to new insights have let us to expect marginal annexin targeting with a 10 minutes delay between reperfusion and administration of Annexin A5) | |||
| Does Caffeine Reduce Rosuvastatin-Induced Protection Against Ischemia-Reperfusion Injury?[NCT00457652] | Phase 4 | 24 participants (Actual) | Interventional | 2007-06-30 | Completed | ||
| Pilot Study for the Development of Transient Forearm Endothelial Dysfunction[NCT00453531] | Phase 1/Phase 2 | 6 participants (Actual) | Interventional | 2007-03-26 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for phentolamine and Active Hyperemia
| Article | Year |
|---|---|
A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbances.
Topics: Adult; Contrast Sensitivity; Female; Glare; Humans; Hyperemia; Male; Middle Aged; Night Blindness; N | 2022 |
Adenosine receptor antagonist and augmented vasodilation during hypoxic exercise.
Topics: Adenosine; Adrenergic alpha-Antagonists; Adult; Aminophylline; Blood Flow Velocity; Blood Pressure; | 2009 |
Flow-mediated dilation of the radial artery is offset by flow-induced reduction in transmural pressure.
Topics: Adrenergic alpha-Antagonists; Adult; Analysis of Variance; Blood Pressure; Brachial Artery; Endothel | 2011 |
Metabolic forearm vasodilation is enhanced following Bier block with phentolamine.
Topics: Adrenergic alpha-Antagonists; Adult; Autonomic Nerve Block; Blood Flow Velocity; Blood Pressure; Blo | 2007 |
Influence of nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia.
Topics: Adenosine; Adrenergic alpha-Antagonists; Adult; Arginine; Blood Pressure; Coronary Circulation; Coro | 2001 |
21 other studies available for phentolamine and Active Hyperemia
| Article | Year |
|---|---|
Ventilatory, hemodynamic, sympathetic nervous system, and vascular reactivity changes after recurrent nocturnal sustained hypoxia in humans.
Topics: Acclimatization; Adrenergic alpha-Antagonists; Adult; Blood Pressure; Circadian Rhythm; Female; Fore | 2008 |
Ventilatory, hemodynamic, sympathetic nervous system, and vascular reactivity changes after recurrent nocturnal sustained hypoxia in humans.
Topics: Acclimatization; Adrenergic alpha-Antagonists; Adult; Blood Pressure; Circadian Rhythm; Female; Fore | 2008 |
Ventilatory, hemodynamic, sympathetic nervous system, and vascular reactivity changes after recurrent nocturnal sustained hypoxia in humans.
Topics: Acclimatization; Adrenergic alpha-Antagonists; Adult; Blood Pressure; Circadian Rhythm; Female; Fore | 2008 |
Ventilatory, hemodynamic, sympathetic nervous system, and vascular reactivity changes after recurrent nocturnal sustained hypoxia in humans.
Topics: Acclimatization; Adrenergic alpha-Antagonists; Adult; Blood Pressure; Circadian Rhythm; Female; Fore | 2008 |
Ventilatory, hemodynamic, sympathetic nervous system, and vascular reactivity changes after recurrent nocturnal sustained hypoxia in humans.
Topics: Acclimatization; Adrenergic alpha-Antagonists; Adult; Blood Pressure; Circadian Rhythm; Female; Fore | 2008 |
Ventilatory, hemodynamic, sympathetic nervous system, and vascular reactivity changes after recurrent nocturnal sustained hypoxia in humans.
Topics: Acclimatization; Adrenergic alpha-Antagonists; Adult; Blood Pressure; Circadian Rhythm; Female; Fore | 2008 |
Ventilatory, hemodynamic, sympathetic nervous system, and vascular reactivity changes after recurrent nocturnal sustained hypoxia in humans.
Topics: Acclimatization; Adrenergic alpha-Antagonists; Adult; Blood Pressure; Circadian Rhythm; Female; Fore | 2008 |
Ventilatory, hemodynamic, sympathetic nervous system, and vascular reactivity changes after recurrent nocturnal sustained hypoxia in humans.
Topics: Acclimatization; Adrenergic alpha-Antagonists; Adult; Blood Pressure; Circadian Rhythm; Female; Fore | 2008 |
Ventilatory, hemodynamic, sympathetic nervous system, and vascular reactivity changes after recurrent nocturnal sustained hypoxia in humans.
Topics: Acclimatization; Adrenergic alpha-Antagonists; Adult; Blood Pressure; Circadian Rhythm; Female; Fore | 2008 |
De Motu Arteriarum: hemodynamics and arterial function in humans.
Topics: Adrenergic alpha-Antagonists; Blood Pressure; Brachial Artery; Endothelium, Vascular; Enzyme Inhibit | 2011 |
Augmented skeletal muscle hyperaemia during hypoxic exercise in humans is blunted by combined inhibition of nitric oxide and vasodilating prostaglandins.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Cyclooxygenase Inhibitors; Exercise; Fema | 2011 |
Preserved alpha-adrenergic tone in the leg vascular bed of spinal cord-injured individuals.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Blood Pressure; Cold Temperature; | 2003 |
Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses.
Topics: Adrenergic alpha-Antagonists; Blood Pressure; Coronary Artery Disease; Coronary Circulation; Coronar | 2004 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Topics: Adenosine; Adolescent; Adult; Annexin A5; Apoptosis; Drug Administration Schedule; Exercise Test; Fo | 2005 |
Effect of phentolamine on the hyperemic response to adenosine in patients with microvascular disease.
Topics: Adenosine; Adrenergic alpha-Antagonists; Blood Flow Velocity; Coronary Angiography; Coronary Stenosi | 2005 |
Impact of type 2 diabetes on nitric oxide and adrenergic modulation of myocardial perfusion.
Topics: Adenosine; Adrenergic alpha-Antagonists; Blood Pressure; Coronary Circulation; Diabetes Mellitus, Ty | 2007 |
An acute ocular inflammatory reaction induced by intravitreal bovine serum albumin in presensitized rabbits: the effect of phentolamine.
Topics: Animals; Aqueous Humor; Eye Proteins; Female; Hyperemia; Immunization; Injections; Intraocular Press | 1984 |
Does sympathetic activation blunt nitric oxide-mediated hyperemia in the human forearm?
Topics: Acetylcholine; Adolescent; Adult; Bretylium Compounds; Drug Combinations; Female; Forearm; Humans; H | 1997 |
Tonic influence of the sympathetic nervous system on myocardial reactive hyperemia and on coronary blood flow distribution in dogs.
Topics: Animals; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Endocardium; Hemodynamics; | 1977 |
Direct measurement of arteriovenous anastomotic blood flow after lumbar sympathectomy.
Topics: Animals; Arteriovenous Anastomosis; Blood Flow Velocity; Capillaries; Dogs; Female; Femoral Artery; | 1977 |
Influence of alpha- and beta-sympathetic blockade on hypoxic sensitivity of the coronaries.
Topics: Adaptation, Physiological; Animals; Coronary Circulation; Coronary Vessels; Dilatation; Dogs; Hypere | 1976 |
Neurogenic influences on the coronary vascular response to ischemia in the awake dog.
Topics: Animals; Autonomic Nervous System; Blood Pressure; Constriction; Coronary Circulation; Coronary Vess | 1975 |
Mechanisms of intrarenal hemodynamic changes following acute arterial occlusion.
Topics: Angiotensin II; Animals; Blood Pressure; Diphenhydramine; Dogs; Epinephrine; Hemodynamics; Histamine | 1963 |
Postocclusive vascular responses in isolated perfused kidney of rabbits.
Topics: Acetylcholine; Angiotensin II; Animals; Atropine; Carbon Dioxide; Constriction; Dilatation; Hydrogen | 1972 |
A comparison of regional blood flow and oxygen utilization during dynamic forearm exercise in normal subjects and patients with congestive heart failure.
Topics: Adult; Aged; Dilatation; Epinephrine; Forearm; Heart Failure; Humans; Hyperemia; Ischemia; Middle Ag | 1974 |
Inhibition of constriction-induced reactive hyperemic edema.
Topics: Alphaprodine; Animals; Atropine; Constriction; Edema; Epinephrine; Hexamethonium Compounds; Hindlimb | 1972 |
Septic shock: hemodynamic cost of inflammation.
Topics: Animals; Arteries; Calcium Chloride; Dogs; Hemodynamics; Hindlimb; Hyperemia; Inflammation; Methylpr | 1970 |
Pharmacological blockade of carcinoid flushing provoked by catecholamines and alcohol.
Topics: Bradykinin; Catecholamines; Dopamine; Epinephrine; Ethanol; Humans; Hyperemia; Kallikreins; Malignan | 1971 |
A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure.
Topics: Adult; Forearm; Heart Failure; Hot Temperature; Humans; Hyperemia; Leg; Middle Aged; Nitrites; Phent | 1968 |